Biomarkers of endometriosis: How far have we come and where are we going?

Biomarkers of endometriosis: How far have we come and where are we going? DOI: https://doi.org/10.6016/ZdravVestn.3056Keywords: endometriosis, diagnosis, biomarkers, proteomics, hypothesis generatingAbstract Endometriosis is a common gynaecological disease that is characterized by endometrium-like tissue outside the uterine cavity. Endometriosis significantly compromises the quality of life of women and is a major cause of infertility. The gold standard for diagnosis of endometriosis is visual inspection by laparoscopy, which significantly prolongs the time to final diagnosis. This lack of non-invasive diagnostic approaches is why the discovery of biomarkers for endometriosis has been defined as a research priority. In this report, we describe hypothesis-driven and hypothesis-generating approaches for biomarker discovery, along with some important potential biomarkers of endometriosis and their diagnostic characteristics, sensitivities, and specificities. Finally, we present our perspective on the discovery of biomarkers for endometriosis, and discuss some results from our previous and more recent studies. Future studies must focus on improving patient quality of life rather than on discovering significant differences, and therefore close collaboration between clinicians and pre-clinical researchers is essential. Downloads References 1. Rogers PA, D’Hooghe TM, Fazleabas A, Giudice LC, Montgomery GW, Petraglia G, et al. Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France. Reprod Sci. 2013;20(5):483-9. DOI: 10.1177/1933719113477495 2. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol. 1927;14(4):422-69. DOI: 10.1016/S0002-9378(15)30003-X 3. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al.; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400-12. DOI: 10.1093/humrep/det457 PMID: 24435778 4. Rižner TL. Diagnostic potential of peritoneal fluid biomarkers of endometriosis. Expert Rev Mol Diagn. 2015;15(4):557-80. DOI: 10.1586/14737159.2015.1015994 PMID: 25719220 5. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511-9. DOI: 10.1016/j.fertnstert.2012.06.029 PMID: 22819144 6. Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest. 2006;62(3):139-47. DOI: 10.1159/000093121 PMID: 16679772 7. Rogers PA, Adamson GD, Al-Jefout M, Becker CM, D’Hooghe TM, Dunselman GA, et al.; WES/WERF Consortium for Research Priorities in Endometriosis. Research priorities for endometriosis. Reprod Sci. 2017;24(2):202-26. DOI: 10.1177/1933719116654991 PMID: 27368878 8. Biomarkers Definitions Working Group.Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95. DOI: 10.1067/mcp.2001.113989 PMID: 11240971 9. Guo Y, Fu Z, Van Eyk JE. A proteomic primer for the clinician. Proc Am Thorac Soc. 2007;4(1):9-17. DOI: 10.1513/pats.200608-156JG PMID: 17202286 10. Surinova S, Schiess R, Hüttenhain R, Cerciello F, Wollscheid B, Aebersold R. On the development of plasma protein biomarkers. J Proteome Res. 2011;10(1):5-16. DOI: 10.1021/pr1008515 PMID: 21142170 11. Fassbender A, Vodolazkaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, et al. Biomarkers of endometriosis. Fertil Steril. 2013;99(4):1135-45. DOI: 10.1016/j.fertnstert.2013.01.097 PMID: 23414923 12. Fassbender A. Biomarkers of endometriosis. In: Harada TE, editor. Endometriosis: Pathogenesis and Treatment. Berlin: Springer; 2014. pp. 321-39. 13. Rižner TL. Noninvasive biomarkers of endometriosis: myth or reality? Expert Rev Mol Diagn. 2014;14(3):365-85. DOI: 10.1586/14737159.2014.899905 PMID: 24649822 14. Fassbender A, Burney RO, Dorien FO, D’Hooghe T, Giudice L. Update on biomarkers for the detection of endometriosis. BioMed Res Int. 2015;2015:130854. DOI: 10.1155/2015/130854 PMID: 26240814 15. Nisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;5(5):CD012179. DOI: 10.1002/14651858.CD012179 PMID: 27132058 16. Machairiotis N, Stylianaki A, Dryllis G, Zarogoulidis P, Kouroutou P, Tsiamis N, et al. Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagn Pathol. 2013;8(1):194. DOI: 10.1186/1746-1596-8-194 PMID: 24294950 17. Ahn SH, Singh V, Tayade C. Biomarkers in endometriosis: challenges and opportunities. Fertil Steril. 2017;107(3):523-32. DOI: 10.1016/j.fertnstert.2017.01.009 PMID: 28189296 18. Rawson JM. Prevalence of endometriosis in asymptomatic women. J Reprod Med. 1991;36(7):513-5. PMID: 1834839 19. Thomas EJ. The relevance of asymptomatic endometriosis. Hum Reprod. 1996;11(3):103-9. DOI: 10.1093/humrep/11.suppl_3.103 PMID: 9147105 20. Rizner TL, Adamski J. Paramount importance of sample quality in pre-clinical and clinical research-Need for standard operating procedures (SOPs). J Steroid Biochem Mol Biol. 2019;186:1-3. DOI: 10.1016/j.jsbmb.2018.09.017 PMID: 30261262 21. Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update. 1998;4(5):741-51. DOI: 10.1093/humupd/4.5.741 PMID: 10027629 22. Young VJ, Brown JK, Saunders PT, Horne AW. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update. 2013;19(5):558-69. DOI: 10.1093/humupd/dmt024 PMID: 23720497 23. Bedaiwy MA, Falcone T. Peritoneal fluid environment in endometriosis. Clinicopathological implications. Minerva Ginecol. 2003;55(4):333-45. PMID: 14581858 24. Gupta D, Hull ML, Fraser I, Miller L, Bossuyt PM, Johnson N, et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;4:CD012165. DOI: 10.1002/14651858.CD012165 PMID: 27094925 25. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010;16(6):651-74. DOI: 10.1093/humupd/dmq009 PMID: 20462942 26. Burney RO. Biomarker development in endometriosis. Scand J Clin Lab Invest Suppl. 2014;244:75-81. DOI: 10.3109/00365513.2014.936692 PMID: 25083898 27. Lanišnik Rižner T. Molecular biomarkers of endometriosis – options for non-invasive diagnostics? Zdrav Vestn. 2014;83:782-91. 28. Ekarattanawong S, Tanprasertkul C, Somprasit C, Chamod P, Tiengtip R, Bhamarapravatana K, et al. Possibility of using superoxide dismutase and glutathione peroxidase as endometriosis biomarkers. Int J Womens Health. 2017;9:711-6. DOI: 10.2147/IJWH.S141021 PMID: 29026339 29. Scutiero G, Iannone P, Bernardi G, Bonaccorsi G, Spadaro S, Volta CA, et al. Oxidative stress and endometriosis: a systematic review of the literature. Oxid Med Cell Longev. 2017;2017:7265238. DOI: 10.1155/2017/7265238 PMID: 29057034 30. Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril. 1998;70(6):1101-8. DOI: 10.1016/S0015-0282(98)00355-0 PMID: 9848302 31. Hirsch M, Duffy J, Davis CJ, Nieves Plana M, Khan KS; International Collaboration to Harmonise Outcomes and Measures for Endometriosis. Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis. BJOG. 2016;123(11):1761-8. DOI: 10.1111/1471-0528.14055 PMID: 27173590 32. Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer. 2009;100(8):1315-9. DOI: 10.1038/sj.bjc.6605011 PMID: 19337252 33. Szubert M, Suzin J, Wierzbowski T, Kowalczyk-Amico K. CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results. Arch Med Sci. 2012;8(3):504-8. DOI: 10.5114/aoms.2012.29529 PMID: 22852007 34. Knific T, Vouk K, Vogler A, Osredkar J, Gstöttner M, Wenzl R, et al. Models including serum CA-125, BMI, cyst pathology, dysmenorrhea or dyspareunia for diagnosis of endometriosis. Biomarkers Med. 2018;12(7):737-47. DOI: 10.2217/bmm-2017-0426 PMID: 29865858 35. Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2:CD009591. DOI: 10.1002/14651858.CD009591.pub2 PMID: 26919512 36. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010;16(6):651-74. DOI: 10.1093/humupd/dmq009 PMID: 20462942 37. Kocbek V, Vouk K, Bersinger NA, Mueller MD, Lanišnik Rižner T. Panels of cytokines and other secretory proteins as potential biomarkers of ovarian endometriosis. J Mol Diagn. 2015;17(3):325-34. DOI: 10.1016/j.jmoldx.2015.01.006 PMID: 25797583 38. Knific T, Fishman D, Vogler A, Gstöttner M, Wenzl R, Peterson H, et al. Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls. Sci Rep. 2019;9(1):16738. DOI: 10.1038/s41598-019-52899-8 PMID: 31723213 39. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod. 2002;17(2):426-31. DOI: 10.1093/humrep/17.2.426 PMID: 11821289 40. Mihalyi A, Gevaert O, Kyama CM, Simsa P, Pochet N, De Smet F, et al. Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod. 2010;25(3):654-64. DOI: 10.1093/humrep/dep425 PMID: 20007161 41. Vodolazkaia A, El-Aalamat Y, Popovic D, Mihalyi A, Bossuyt X, Kyama CM, et al. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Hum Reprod. 2012;27(9):2698-711. DOI: 10.1093/humrep/des234 PMID: 22736326 42. O DF, Waelkens E, Peterse DP, Lebovic D, Meuleman C, Tomassetti C, et al. Evaluation of total, active, and specific myeloperoxidase levels in women with and without endometriosis. Gynecol Obstet Invest. 2018;83(2):133-9. DOI: 10.1159/000475664 PMID: 28511185 43. Prieto L, Quesada JF, Cambero O, Pacheco A, Pellicer A, Codoceo R, et al. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril. 2012;98(1):126-30. DOI: 10.1016/j.fertnstert.2012.03.052 PMID: 22578534 44. Verit FF, Erel O, Celik N. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod. 2008;23(1):100-4. DOI: 10.1093/humrep/dem340 PMID: 18000171 45. Bragatto FB, Barbosa CP, Christofolini DM, Peluso C, dos Santos AA, Mafra FA, et al. There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study. Reprod Health. 2013;10(1):32. DOI: 10.1186/1742-4755-10-32 PMID: 23799909 46. Brubel R, Bokor A, Pohl A, Schilli GK, Szereday L, Bacher-Szamuel R, et al. Serum galectin-9 as a noninvasive biomarker for the detection of endometriosis and pelvic pain or infertility-related gynecologic disorders. Fertil Steril. 2017;108(6):1016-1025.e2. DOI: 10.1016/j.fertnstert.2017.09.008 PMID: 29202955 47. Karakus S, Sancakdar E, Akkar O, Yildiz C, Demirpence O, Cetin A. Elevated serum CD95/FAS and HIF-1α levels, but not Tie-2 levels, may be biomarkers in patients with severe endometriosis: a preliminary report. J Minim Invasive Gynecol. 2016;23(4):573-7. DOI: 10.1016/j.jmig.2016.01.025 PMID: 26851415 48. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med. 2003;9(5):223-8. DOI: 10.1016/S1471-4914(03)00051-0 PMID: 12763528 49. Huang HF, Hong LH, Tan Y, Sheng JZ. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril. 2004;81(5):1235-9. DOI: 10.1016/j.fertnstert.2003.10.027 PMID: 15136083 50. Malvezzi H, Aguiar VG, Paz CC, Tanus-Santos JE, Penna IA, Navarro PA. Increased circulating MMP-2 levels in infertile patients with moderate and severe pelvic endometriosis. Reprod Sci. 2013;20(5):557-62. DOI: 10.1177/1933719112459234 PMID: 23171686 51. De Sanctis P, Elmakky A, Farina A, Caramelli E, Seracchioli R, Mabrouk M, et al. Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. Gynecol Obstet Invest. 2011;71(2):118-23. DOI: 10.1159/000320752 PMID: 21150162 52. Zubrzycka A, Zubrzycki M, Janecka A, Zubrzycka M. New horizons in the etiopathogenesis and noninvasive diagnosis of endometriosis. Curr Mol Med. 2015;15(8):697-713. DOI: 10.2174/1566524015666150921105218 PMID: 26391550 53. Mohamed ML, El Behery MM, Mansour SA. Comparative study between VEGF-A and CA-125 in diagnosis and follow-up of advanced endometriosis after conservative laparoscopic surgery. Arch Gynecol Obstet. 2013;287(1):77-82. DOI: 10.1007/s00404-012-2539-4 PMID: 22930151 54. Bourlev V, Iljasova N, Adamyan L, Larsson A, Olovsson M. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil Steril. 2010;94(1):52-7. DOI: 10.1016/j.fertnstert.2009.02.019 PMID: 19324337 55. Chen L, Fan R, Huang X, Xu H, Zhang X. Reduced levels of serum pigment epithelium-derived factor in women with endometriosis. Reprod Sci. 2012;19(1):64-9. DOI: 10.1177/1933719111413300 PMID: 22051848 56. Fu G, Che X, Sun Y, Huang X, Xu H, Zhou C, et al. Pigment epithelial-derived factor expression in endometriotic lesions in a rat model of endometriosis. Acta Histochem. 2013;115(4):301-7. DOI: 10.1016/j.acthis.2012.08.006 PMID: 22975116 57. Maia LM, Rocha AL, Del Puerto HL, Petraglia F, Reis FM. Plasma urocortin-1 as a preoperative marker of endometriosis in symptomatic women. Gynecol Endocrinol. 2018;34(3):202-5. DOI: 10.1080/09513590.2017.1380188 PMID: 28925754 58. Coutinho LM, Ferreira MC, Rocha AL, Carneiro MM, Reis FM. New biomarkers in endometriosis. Adv Clin Chem. 2019;89:59-77. DOI: 10.1016/bs.acc.2018.12.002 PMID: 30797471 59. Vouk K, Hevir N, Ribić-Pucelj M, Haarpaintner G, Scherb H, Osredkar J, et al. Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum Reprod. 2012;27(10):2955-65. DOI: 10.1093/humrep/des152 PMID: 22859507 60. Vouk K, Ribič-Pucelj M, Adamski J, Rižner TL. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients. J Steroid Biochem Mol Biol. 2016;159:60-9. DOI: 10.1016/j.jsbmb.2016.02.023 PMID: 26921767 Published Issue Section License The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP. The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal. The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author. The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.